5 Best Stocks to Buy for the Next 10 Years

2. Chimerix, Inc. (NASDAQ:CMRX)

Trailing Twelve Month P/E: 0.78

Chimerix, Inc. (NASDAQ:CMRX) is a healthcare company headquartered in Durham, North Carolina. The firm develops treatments for deadly diseases such as tumors, pancreatic cancer, COVID-19, and leukemia.

Chimerix, Inc. (NASDAQ:CMRX)’s fourth quarter results revealed in March 2023 saw the firm report $814,000 in revenue, which was almost double the consensus estimate of $418,000. As of Q4 2022, 14 of the 943 hedge funds polled by Insider Monkey had bought the firm’s shares.

Chimerix, Inc. (NASDAQ:CMRX)’s largest investor in our database is David Rosen’s Rubric Capital Management which owns 7.5 million shares that are worth $13.9 million.

Follow Chimerix Inc (NASDAQ:CMRX)